Cargando…

Determinant components of newly onset versus improved metabolic syndrome in a population of Iran

This study aimed to determine the risk factors related to regression and progression of metabolic syndrome, in a 4-year cohort study. A total of 540 individuals (≥ 18 years old) participated in both phase of the study. Participants were categorized into 3 categories of regressed, progressed and unch...

Descripción completa

Detalles Bibliográficos
Autores principales: Lankarani, Kamran Bagheri, Honarvar, Behnam, Keshani, Parisa, Raeisi Shahraki, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659336/
https://www.ncbi.nlm.nih.gov/pubmed/33177586
http://dx.doi.org/10.1038/s41598-020-76531-2
_version_ 1783608813654376448
author Lankarani, Kamran Bagheri
Honarvar, Behnam
Keshani, Parisa
Raeisi Shahraki, Hadi
author_facet Lankarani, Kamran Bagheri
Honarvar, Behnam
Keshani, Parisa
Raeisi Shahraki, Hadi
author_sort Lankarani, Kamran Bagheri
collection PubMed
description This study aimed to determine the risk factors related to regression and progression of metabolic syndrome, in a 4-year cohort study. A total of 540 individuals (≥ 18 years old) participated in both phase of the study. Participants were categorized into 3 categories of regressed, progressed and unchanged metabolic syndrome (MetS). Demographic, anthropometric and biochemical parameters were assessed for each individual in both phase. Variables differences (delta: Δ) between the two phase of study were calculated. Unchanged group was considered as baseline category. Based on IDF, MetS had been regressed and progressed in 42 participants (7.7%) and 112 (20.7%) participants respectively, in the second phase. More than 47% of people, whose MetS regressed, experienced also NAFLD regression. Results of multiple variable analysis revealed that increased age, positive Δ-TG, and Δ-FBS, significantly increased the odds of MetS progression based on IDF and ATP III definitions, while negative Δ-HDL and Δ-neutrophil to lymph ration increased the odds of progression. On the other hand, negative Δ-TG and positive Δ-HDL significantly increased the odds of Mets regression based of both IDF and ATP III. Management of hypertriglyceridemia, hyperglycemia, and HDL is a critical, non-invasive and accessible approach to change the trend of MetS.
format Online
Article
Text
id pubmed-7659336
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-76593362020-11-13 Determinant components of newly onset versus improved metabolic syndrome in a population of Iran Lankarani, Kamran Bagheri Honarvar, Behnam Keshani, Parisa Raeisi Shahraki, Hadi Sci Rep Article This study aimed to determine the risk factors related to regression and progression of metabolic syndrome, in a 4-year cohort study. A total of 540 individuals (≥ 18 years old) participated in both phase of the study. Participants were categorized into 3 categories of regressed, progressed and unchanged metabolic syndrome (MetS). Demographic, anthropometric and biochemical parameters were assessed for each individual in both phase. Variables differences (delta: Δ) between the two phase of study were calculated. Unchanged group was considered as baseline category. Based on IDF, MetS had been regressed and progressed in 42 participants (7.7%) and 112 (20.7%) participants respectively, in the second phase. More than 47% of people, whose MetS regressed, experienced also NAFLD regression. Results of multiple variable analysis revealed that increased age, positive Δ-TG, and Δ-FBS, significantly increased the odds of MetS progression based on IDF and ATP III definitions, while negative Δ-HDL and Δ-neutrophil to lymph ration increased the odds of progression. On the other hand, negative Δ-TG and positive Δ-HDL significantly increased the odds of Mets regression based of both IDF and ATP III. Management of hypertriglyceridemia, hyperglycemia, and HDL is a critical, non-invasive and accessible approach to change the trend of MetS. Nature Publishing Group UK 2020-11-11 /pmc/articles/PMC7659336/ /pubmed/33177586 http://dx.doi.org/10.1038/s41598-020-76531-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Lankarani, Kamran Bagheri
Honarvar, Behnam
Keshani, Parisa
Raeisi Shahraki, Hadi
Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title_full Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title_fullStr Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title_full_unstemmed Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title_short Determinant components of newly onset versus improved metabolic syndrome in a population of Iran
title_sort determinant components of newly onset versus improved metabolic syndrome in a population of iran
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659336/
https://www.ncbi.nlm.nih.gov/pubmed/33177586
http://dx.doi.org/10.1038/s41598-020-76531-2
work_keys_str_mv AT lankaranikamranbagheri determinantcomponentsofnewlyonsetversusimprovedmetabolicsyndromeinapopulationofiran
AT honarvarbehnam determinantcomponentsofnewlyonsetversusimprovedmetabolicsyndromeinapopulationofiran
AT keshaniparisa determinantcomponentsofnewlyonsetversusimprovedmetabolicsyndromeinapopulationofiran
AT raeisishahrakihadi determinantcomponentsofnewlyonsetversusimprovedmetabolicsyndromeinapopulationofiran